GC
OYST

Guggenheim Capital’s Oyster Point Pharma, Inc. Common Stock OYST Stock Holding History

Guggenheim Capital’s Portfolio OYST Stock Details OYST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-12,816
Closed -$143K – 2064
2022
Q4 		$143K Buy
+12,816
New +$124K ﹤0.01% 1848

Other funds holding OYST

HNB
Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Guggenheim Capital's OYST Position: Q1 2023 in Review

Guggenheim Capital sold out of Oyster Point Pharma, Inc. Common Stock (OYST) in Q1 2023, closing a stake of 12,816 shares — an estimated $143K sold.

Guggenheim Capital first reported a position in OYST in Q4 2022 and held it in 1 quarter. The position peaked at $143K in Q4 2022. 1 fund tracked by Wall St. Rank holds OYST as of Q1 2023.

  • Guggenheim Capital reported no remaining Oyster Point Pharma, Inc. Common Stock position as of Q1 2023 after selling out during the quarter.
  • Guggenheim Capital sold 12,816 Oyster Point Pharma, Inc. Common Stock shares in Q1 2023, an estimated $143K.
  • Guggenheim Capital first reported a position in Oyster Point Pharma, Inc. Common Stock in Q4 2022 and held it in 1 quarter.
  • Guggenheim Capital's Oyster Point Pharma, Inc. Common Stock position peaked at $143K in Q4 2022.
  • 1 fund tracked by Wall St. Rank held Oyster Point Pharma, Inc. Common Stock as of Q1 2023.

Based on Guggenheim Capital's 13F filing for Q1 2023, filed 11 May 2023.